CLINICAL TRIALS PROFILE FOR VESICARE LS
✉ Email this page to a colleague
All Clinical Trials for VESICARE LS
Trial ID | Title | Status | Sponsor | Phase | Start Date | Summary |
---|---|---|---|---|---|---|
NCT00333112 ↗ | A Study to Evaluate Solifenacin Succinate in Combination With Tamsulosin for the Treatment of Residual Overactive Bladder Symptoms (OAB) in Men. | Completed | Astellas Pharma Inc | Phase 4 | 2006-05-01 | A study to evaluate solifenacin succinate in combination with tamsulosin for the treatment of residual OAB symptoms in men. |
NCT00368706 ↗ | A Double-Blind, Paralleled Study Comparing Efficacy/Safety of Solifenacin to Tolterodine in Overactive Bladder Patients | Completed | Astellas Pharma Inc | Phase 3 | 2006-09-01 | To evaluate the efficacy and safety of solifenacin succinate (Vesicare) 5mg OD in subjects with overactive bladder compared to tolterodine wmg, bid |
NCT00431041 ↗ | Study to Compare the Safety and Efficacy of Solifenacin With Oxybutynin for the Treatment of Overactive Bladder (VECTOR) | Completed | Astellas Pharma Canada, Inc. | Phase 4 | 2006-12-01 | The purpose of this study is to compare the safety and efficacy of solifenacin with oxybutynin immediate-release (IR) for the treatment of overactive bladder (OAB). |
>Trial ID | >Title | >Status | >Sponsor | >Phase | >Start Date | >Summary |
Clinical Trial Conditions for VESICARE LS
Condition Name
Clinical Trial Locations for VESICARE LS
Trials by Country
Clinical Trial Progress for VESICARE LS
Clinical Trial Phase
Clinical Trial Sponsors for VESICARE LS
Sponsor Name